Sleep apnea in fragile X premutation carriers with and without FXTAS.
about
Fragile X spectrum disordersFragile X-associated tremor/ataxia syndrome.Sleep and sleep disorders in rare hereditary diseases: a reminder for the pediatrician, pediatric and adult neurologist, general practitioner, and sleep specialistFragile X syndrome: A review of clinical managementMolecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related DisordersFMR1 CGG allele size and prevalence ascertained through newborn screening in the United StatesAssociated features in females with an FMR1 premutationEmerging topics in FXTAS.Health and reproductive experiences of women with an FMR1 premutation with and without fragile X premature ovarian insufficiency.Molecular Advances Leading to Treatment Implications for Fragile X Premutation CarriersPSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS.Current Gaps in Understanding the Molecular Basis of FXTASDistribution and frequency of intranuclear inclusions in female CGG KI mice modeling the fragile X premutationSimplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis.Prevalence and risk of migraine headaches in adult fragile X premutation carriersFragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS.Transmission of an FMR1 premutation allele in a large family identified through newborn screening: the role of AGG interruptions.Risk Factors for Cognitive Impairment in Fragile X-Associated Tremor/Ataxia Syndrome.Fragile X and Obstructive Sleep Apnea Syndrome: Case Presentation and Management ChallengesImplications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families.Newborn screening and cascade testing for FMR1 mutations.
P2860
Q26824376-3A537CDD-3668-4D1C-BC87-4313C92CF0A0Q26852667-F0661935-77AB-476D-8765-38D549BC5894Q27015026-111A944A-67BB-4BB9-921F-F23C39D8F01EQ28076950-47C537D9-5CEA-46C9-BB04-F2CF930290E5Q28077980-441FC60D-40F2-4B03-83BA-D6D3DD72CF11Q33781086-A2F9339C-2FDA-4D35-9593-ED088AC4CD91Q34000722-20CCDCAF-290D-4EBD-B9ED-2633842158E4Q34077088-D262A682-71E1-41DC-8BB4-36820AB1FD67Q34148608-1ED2C256-4EDF-4B4A-B558-5095AC5B521AQ34575595-B43F8E0E-7EAA-4379-B35E-AB8FC76C8FD6Q35006614-85777015-15A7-40EA-B079-1845A6E9A657Q36048562-EC003618-38FE-4849-8C57-E64299C05113Q36611172-A91029F7-8EBA-4B53-B8C3-B738288E1724Q36811533-D3A8781A-22A4-4CC7-8E0C-0751A39ED8D1Q37191145-A3BD7B45-1129-415D-8CCD-3A9A1B353C40Q37524454-63753262-33ED-4305-8D37-55B464A0EF0DQ37580522-C7ABBEBF-C266-47BD-9E54-9F58DF97F82DQ37663133-8BFD6F4E-F8F5-4C38-A359-5B9B667EE5CFQ37730919-AE0D3260-3F3F-4D23-A0A7-96D04672AAD6Q38959369-4A967F23-6285-4203-AFB9-179BD316FDA1Q39773900-BE7BABC1-8590-44E0-83F2-ED24F744DCBBQ40080863-D31F070A-FB5B-417D-A844-A408BDB945C1Q55501801-F5B47D33-3555-4D48-9D88-8F4D4E3A10C9
P2860
Sleep apnea in fragile X premutation carriers with and without FXTAS.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Sleep apnea in fragile X premutation carriers with and without FXTAS.
@ast
Sleep apnea in fragile X premutation carriers with and without FXTAS.
@en
type
label
Sleep apnea in fragile X premutation carriers with and without FXTAS.
@ast
Sleep apnea in fragile X premutation carriers with and without FXTAS.
@en
prefLabel
Sleep apnea in fragile X premutation carriers with and without FXTAS.
@ast
Sleep apnea in fragile X premutation carriers with and without FXTAS.
@en
P2093
P2860
P356
P1476
Sleep apnea in fragile X premutation carriers with and without FXTAS.
@en
P2093
Alyssa Hamlin
Danh V Nguyen
Flora Tassone
Randi J Hagerman
P2860
P304
P356
10.1002/AJMG.B.31237
P577
2011-09-19T00:00:00Z